Companies
- Companies
- Browse
Companies
Out-licensing / sale / co-development of Benzaldehyde-derivative anti-cancer compounds More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2008 - 148 pages - $1,740
Aug 2010 - 40 pages - $250
Oct 2010 - 31 pages - $895
May 2011 - 31 pages - $895
Dec 2010 - 30 pages - $500
Aug 2010 - 33 pages - $250
Sep 2009 - 29 pages - $895
Dec 2010 - 41 pages - $500
Mar 2011 - 41 pages - $500
Aug 2010 - 36 pages - $250
Your selection
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Manufacturing
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Appendicitis
- Cholangitis, sclerosing
- Colitis
- Colitis, ulcerative
- Constipation
- Crohn's disease
- Diarrhea
- Dyspepsia
- Electrolyte replacement
- Emesis
- Emesis, motion
- Esophagitis
- Flatulence
- Food poisoning
- Gastritis
- Gastroesophageal reflux disorder
- Gastrointestinal (other)
- Gastrointestinal secretions
- Gastroprokinetic
- Helicobacter pylori
- Inflammatory bowel disease
- Irritable bowel syndrome
- Nausea
- Pancreatitis
- Ulcer
- Ulcer, gastric
- Ulcer, gastroduodenal
- Ulcer, peptic
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us